Gut microbiota profiles in treatment-naïve children with attention deficit hyperactivity disorderOriginal paper
What was studied?
This study asked whether the gut microbiota differs in children with attention-deficit/hyperactivity disorder (ADHD) and whether any differences track with symptom severity. Researchers used high-throughput pyrosequencing of fecal samples to profile bacterial composition. They compared microbiota structure between children with ADHD and healthy controls. They also correlated specific taxa with parent-reported symptom scores. The design was cross-sectional and observational, so it describes associations rather than cause.
Who was studied?
The cohort was 51 treatment-naive children with ADHD and 32 healthy control children. All were human participants, and the ADHD group had received no prior medication for the condition. Stool samples provided the microbial material. The study was conducted in China. Using treatment-naive children helps separate microbiota patterns of ADHD itself from effects of stimulant medication.
What were the most important findings?
An operational taxonomic unit analysis showed a significant decrease in Faecalibacterium in children with ADHD compared with healthy controls. Within the ADHD group, Faecalibacterium abundance was negatively associated with parent-reported ADHD symptoms, so lower levels tracked with more severe symptoms. There was no significant difference in alpha diversity between the ADHD and control groups. So the signal was a specific taxon shift, not a broad loss of overall diversity.
What are the greatest implications of this study?
The findings suggest Faecalibacterium may be a candidate microbiota marker linked to ADHD in children. Because Faecalibacterium is a known butyrate producer, its depletion offers a plausible gut-brain axis connection worth further study. The design cannot establish causation or direction. Temporal and interventional studies are needed to test whether this bacterium influences symptoms or simply reflects them.